Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 17,097Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Abacus Medicine A/S

02 2Pfizer Ag

03 3Pfizer Europe MA EEIG (1)

04 6Pfizer Europe Ma Eeig

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

02

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

03

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 06/05/2019

Application Number : 20180110000054

Regulatory Info : Approved

Registration Country : Sweden

blank

04

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date : 06/05/2019

Application Number : 20180110000047

Regulatory Info : Approved

Registration Country : Sweden

blank

05

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinibum

Brand Name : Lorviqua film-coated tablets

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date : 19/02/2020

Application Number : 66941

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinibum

Brand Name : Lorviqua film-coated tablets

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 19/02/2020

Application Number : 66941

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

08

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

09

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

blank

10

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

Lorlatinib

Brand Name : Lorviqua

Dosage Form : Film-Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank